Recalls & Warnings September 08, 2012 Medifast Settles False Advertising Suit On September 7, 2012, Jason Pharmaceuticals Inc., a wholly owned subsidiary of Medifast, agreed to pay a $3.7 million civil penalty and meet new compliance requirements as part of a settlement with the U.S
PMID: 7518857 Pullar JM, Carr AC, Vissers MCM
In a job posting currently live on its website, the company seeks a senior research scientist with a commercial mindset. After all, it reads: we are in the business of monetizing products and ideas, not conducting research for the sake of research. To submit a correction request, please visit our Contact Us page.
This pattern is consistent with what researchers see across the category, whether the medication targets the GLP-1 pathway or works as an amylin analog
In This Article Top 8 Glutathione Rich Foods For Glowing & Healthy Skin Achieving luminous and youthful skin is a goal many of us share, and it often begins with what we put on our plates